Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS‐mutant Cancers by Yafang Wang, Lansong Xu, Lijun Ling, Mingyue Yao, Shangxuan Shi, Chengcheng Yu, Yingnian Li, Jie Shen, Hualiang Jiang, Chengying Xie

Subjects: Get full text

Integrated bioinformatics and functional studies identify CDK9 as a potential prognostic biomarker and therapeutic target in AML by Zhibin Xie, Yang Xia, Zhongyu Li, Mengmeng Zhang, Yuanyuan Tan, Yuqing Han, Meng Wang, Pingping Zhang, Jiajia Li

Subjects: “…CDK9…”
Get full text

Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target by Sara Patrizi, Silvia Vallese, Sabina Barresi, Matteo Cassandri, Isabella Giovannoni, Lucia Pedace, Luana Abballe, Flavia Vinciarelli, Celeste Antonacci, Alessandra Stracuzzi, Barbara Mancini, Ida Russo, Angela Di Giannatale, Rossella Rota, Rita Alaggio, Franco Locatelli, Giuseppe Maria Milano, Evelina Miele

Subjects: “…Transcriptome sequencing, Targeted therapies, CDK9…”
Get full text

Targeting CDK9 for treatment of colorectal cancer by Muhammed H. Rahaman, Frankie Lam, Longjin Zhong, Theodosia Teo, Julian Adams, Mingfeng Yu, Robert W. Milne, Chris Pepper, Noor A. Lokman, Carmela Ricciardelli, Martin K. Oehler, Shudong Wang

Subjects: Get full text

BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis by Yijin Chen, Dawei Huo, Ye Meng, Jie Zhang, Mengmeng Huang, Qian Luo, Yulin Xu, Haiqiong Zheng, Yingli Han, Xiangjun Zeng, Yanjuan Liu, Yunfei Liu, Rui Wen, Delin Kong, Ruxiu Tie, Shanshan Pei, Nan Liu, Pengxu Qian, He Huang, Meng Zhang

Subjects: Get full text

Innovative discovery and mechanistic validation of HyT-PD ligands for selective CDK9-targeted protein degradation by Yizhan Zhai, Jianfeng Cai

Subjects: Get full text

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico by Kaori Asamitsu, Takatsugu Hirokawa, Takashi Okamoto

Subjects: “…Cyclin dependent kinase (CDK) 9…”
Get full text

First ATG101-recruiting small molecule degrader for selective CDK9 degradation via autophagy–lysosome pathway by Ye Zhong, Jing Xu, Huiying Cao, Jie Gao, Shaoyue Ding, Zhaohui Ren, Huali Yang, Yili Sun, Maosheng Cheng, Jia Li, Yang Liu

Subjects: Get full text

Identification of new inhibitors of the kinase acti­vity of CDK2 and CDK9 by molecular modeling and high-efficiency screening by G.V. Andrianov, I.G. Serebriiskii

Subjects: Get full text